Barclays’s Tiziana Life Sciences TLSA Stock Holding History

Barclays’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-47,500	Closed	-$33.1K	–	5550
2024 Q4	$33.1K	Hold	47,500	–	–	﹤0.01%	4845
2024 Q3	$45.6K	Hold	47,500	–	–	﹤0.01%	4766
2024 Q2	$43.7K	Buy	47,500 +30,000	+171%	+$21.9K	﹤0.01%	4255
2024 Q1	$7.95K	Hold	17,500	–	–	﹤0.01%	4827
2023 Q4	$9.8K	Hold	17,500	–	–	﹤0.01%	4971
2023 Q3	$11.5K	Hold	17,500	–	–	﹤0.01%	4280
2023 Q2	$11.9K	Hold	17,500	–	–	﹤0.01%	4208
2023 Q1	$19.1K	Hold	17,500	–	–	﹤0.01%	4666
2022 Q4	$10.5K	Hold	17,500	–	–	﹤0.01%	4919
2022 Q3	$14K	Hold	17,500	–	–	﹤0.01%	4189
2022 Q2	$13K	Hold	17,500	–	–	﹤0.01%	4549
2022 Q1	$18K	Buy	+17,500	New	+$15.5K	﹤0.01%	4473
2021 Q4	–	Sell	-96	Closed	–	–	4731
2021 Q3	$0	Sell	96 -95	-50%	-$175	﹤0.01%	5011
2021 Q2	$0	Hold	191	–	–	﹤0.01%	5076
2021 Q1	$1K	Buy	+191	New	+$634	﹤0.01%	4611
2020 Q1	–	Sell	-31,238	Closed	-$34K	–	6450
2019 Q4	$34K	Buy	+31,238	New	+$34.4K	﹤0.01%	5854

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Barclays's TLSA Position: Q1 2025 in Review

Barclays sold out of Tiziana Life Sciences (TLSA) in Q1 2025, closing a stake of 47,500 shares — an estimated $33.1K sold.

Barclays first reported a position in TLSA in Q4 2019 and held it in 16 quarters. The position peaked at $45.6K in Q3 2024. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2025.

Barclays reported no remaining Tiziana Life Sciences position as of Q1 2025 after selling out during the quarter.
Barclays sold 47,500 Tiziana Life Sciences shares in Q1 2025, an estimated $33.1K.
Barclays first reported a position in Tiziana Life Sciences in Q4 2019 and held it in 16 quarters.
Barclays's Tiziana Life Sciences position peaked at $45.6K in Q3 2024.
32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.